Heart rate and B-blockade in stable XXXX in Greece.

@entity1 @entity662 @entity583 @entity565 @entity2998 @entity3979 @entity741 @entity1030 @entity453
INTRODUCTION: Heart rate (HR) is a strong prognostic indicator in @entity1 with @entity453 ( @entity453 ). However, there is only limited evidence on HR and the use of b-blockers in @entity1 with @entity453 in contemporary clinical practice. METHODS: CLARIFY is an international, prospective, observational, longitudinal registry of outpatients with stable @entity453 , defined as prior @entity583 or revascularization procedure, evidence of @entity3979 >50%, or @entity662 associated with proven @entity741 . A total of 33,283 @entity1 from 45 countries were enrolled between November 2009 and July 2010; of these, 559 @entity1 were enrolled in Greece (age 62.3    10.6 years, 84.44% @entity1 ). RESULTS: HR measured by pulse was 68.3    10.2 bpm and by electrocardiogram 67.6    10.9, with an excellent correlation (r=0.91, p<0.001). Overall, 42.8% had HR70 bpm. B-blockers were prescribed in 74.2% of @entity1 . Resting HR by pulse on b-blocker was 67.8 bpm and without b-blocker 69.6 bpm (p=0.069). HR70 bpm was independently associated with a lack of physical activity, higher systolic blood pressure, and a higher prevalence of @entity565 or @entity1030 and @entity2998 . CONCLUSION: Despite the use of HR lowering agents, the percentage of @entity1 with HR70 bpm was high. It is likely that we can further improve HR control in Greek @entity1 with stable @entity453 by both increasing the prescription of b-blockers and up-titrating their dose, as well as by using and up-titrating other available HR lowering agents.
